Exciva

GermanyHeidelbergBiotech & PharmaSeries B

Overview

Where Exciva is now

Exciva announced a Series B round of €51M on 20 January 2026, led by Gimv and EQT Life Sciences.

Observed Described in the funding announcement as "biopharmaceutical company developing new therapeutic compounds for the treatment of neuropsychiatric conditions". Source

Latest round
Series B
Amount
€51M
Announced
20 January 2026
Headquarters
Heidelberg, Germany
Sector
Biotech & Pharma
Investors
Gimv and EQT Life Sciences
Also participating
Not stated
Relevant leadership
Not stated

Momentum Inferred

AfterRaise Score

46
Steady growth
0 funding signals in the last 90 days
Funding recency
9/40
announced within the last year
Round scale
19/25
round size relative to the market
Funding stage
18/20
Series B
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Growth timeline

What has happened so far

  • 20 January 2026
    €51M Series B
    Led by Gimv and EQT Life Sciences.

Observed The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

Moves

Published by the company

Share a Move

No company-published Moves yet

AfterRaise has the funding facts for Exciva from public sources. What it does not have is what the company is doing next, in the company's own words. That part only they can write.

Work here? Publish the first Move

Opportunities

Work this company has opened

No open Opportunities listed

Jobs, projects, partnerships and advisory needs appear here once the company has claimed its room and published them.

Work here? Open the first one

Open to

Who may approach Exciva

Not yet specified

Exciva has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

This room belongs to Exciva.

Claim it to publish Moves in your own words, open Opportunities, choose who may approach you, and see the offers of help you have received. Everything you publish is reviewed before it appears.

Also moving

Other Biotech & Pharma companies

See the sector